Literature DB >> 25941435

Acute-on-Chronic Liver Failure: Recent Concepts.

Richard Moreau1, Rajiv Jalan2, Vicente Arroyo3.   

Abstract

A proportion of patients hospitalized for an acute complication of cirrhosis are at high risk of short-term death. The term Acute-on-Chronic Liver Failure (ACLF) is used to characterize these patients. Until recently there was no evidence-based definition of ACLF. In 2013 a definition has been proposed based on results of a large prospective observational European study, called "European Association for the Study of the Liver (EASL)-Chronic Liver Failure (CLIF) Consortium Acute-on-Chronic Liver Failure in Cirrhosis (CANONIC)" study. Results of this study led to elaborate new concepts about ACLF. First, it was found that ACLF is a syndrome that is distinct from mere decompensated cirrhosis. It was also shown that ACLF is a dynamic syndrome which can improve or conversely worsen. Patients who worsen die rapidly from multiorgan failures. The CANONIC study also found that identifiable precipitating events (e.g., bacterial infection, active alcoholism) are found in only 50% of cases of ACLF indicating that these events are dispensable for defining ACLF. In addition precipitating events may be initiators of ACLF but do not drive the outcome. An important concept derived from the CANONIC study is that ACLF is associated with systemic inflammation even in patients who do not have identifiable precipitating events. Finally it was found that ACLF may develop in patients without prior episodes of decompensation or in those with recent decompensation (<3 months). Moreover these patients with "early" ACLF were more severe than patients who developed ACLF after a long of history of decompensated cirrhosis.

Entities:  

Keywords:  ACLF, acute-on-chronic liver failure; AD, acute decompensation; CANONIC, Consortium Acute-on-Chronic Liver Failure in Cirrhosis; CLIF, chronic liver failure; CRP, C-reactive protein; EASL, European Association for the Study of the Liver; INR, international normalized ratio; SBP, spontaneous bacterial peritonitis; SOFA, sequential organ failure assessment; cirrhosis; inflammation; organ failures

Year:  2014        PMID: 25941435      PMCID: PMC4415197          DOI: 10.1016/j.jceh.2014.09.003

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  19 in total

1.  Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.

Authors:  M Navasa; A Follo; X Filella; W Jiménez; A Francitorra; R Planas; A Rimola; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

2.  Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Authors:  Richard Moreau; Francois Durand; Thierry Poynard; Christian Duhamel; Jean-Paul Cervoni; Philippe Ichaï; Armand Abergel; Chantal Halimi; Mathieu Pauwels; Jean-Pierre Bronowicki; Emile Giostra; Cathy Fleurot; Danielle Gurnot; Olivier Nouel; Philippe Renard; Michel Rivoal; Pierre Blanc; Dimitri Coumaros; Sylvie Ducloux; Stephane Levy; Alexandre Pariente; Jean-Marc Perarnau; Jean Roche; Myriam Scribe-Outtas; Dominique Valla; Brigitte Bernard; Didier Samuel; Joël Butel; Antoine Hadengue; Andrzej Platek; Didier Lebrec; Jean-Francois Cadranel
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.

Authors:  Ezequiel Rodríguez; Chiara Elia; Elsa Solà; Rogelio Barreto; Isabel Graupera; Alida Andrealli; Gustavo Pereira; Maria Poca; Jordi Sánchez; Mónica Guevara; Germán Soriano; Carlo Alessandria; Javier Fernández; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2014-01-18       Impact factor: 25.083

4.  Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.

Authors:  Vishal Garg; Hitendra Garg; Arshi Khan; Nirupama Trehanpati; Ashish Kumar; Barjesh Chander Sharma; Puja Sakhuja; Shiv Kumar Sarin
Journal:  Gastroenterology       Date:  2011-11-23       Impact factor: 22.682

5.  Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.

Authors:  Hitendra Garg; Shiv Kumar Sarin; Manoj Kumar; Vishal Garg; Barjesh Chander Sharma; Ashish Kumar
Journal:  Hepatology       Date:  2011-02-03       Impact factor: 17.425

6.  Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival.

Authors:  Vincent Das; Pierre-Yves Boelle; Arnaud Galbois; Bertrand Guidet; Eric Maury; Nicolas Carbonell; Richard Moreau; Georges Offenstadt
Journal:  Crit Care Med       Date:  2010-11       Impact factor: 7.598

Review 7.  Acute-on chronic liver failure.

Authors:  Rajiv Jalan; Pere Gines; Jody C Olson; Rajeshwar P Mookerjee; Richard Moreau; Guadalupe Garcia-Tsao; Vicente Arroyo; Patrick S Kamath
Journal:  J Hepatol       Date:  2012-06-28       Impact factor: 25.083

8.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

9.  Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.

Authors:  Dominique Thabut; Julien Massard; Alice Gangloff; Nicolas Carbonell; Claire Francoz; Eric Nguyen-Khac; Christian Duhamel; Didier Lebrec; Thierry Poynard; Richard Moreau
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.

Authors:  Rajiv Jalan; Faouzi Saliba; Marco Pavesi; Alex Amoros; Richard Moreau; Pere Ginès; Eric Levesque; Francois Durand; Paolo Angeli; Paolo Caraceni; Corinna Hopf; Carlo Alessandria; Ezequiel Rodriguez; Pablo Solis-Muñoz; Wim Laleman; Jonel Trebicka; Stefan Zeuzem; Thierry Gustot; Rajeshwar Mookerjee; Laure Elkrief; German Soriano; Joan Cordoba; Filippo Morando; Alexander Gerbes; Banwari Agarwal; Didier Samuel; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2014-06-17       Impact factor: 25.083

View more
  14 in total

1.  Plasma exchange for acute on chronic liver failure: is there a light at the end of the tunnel?

Authors:  Rakhi Maiwall; Richard Moreau
Journal:  Hepatol Int       Date:  2016-02-04       Impact factor: 6.047

2.  Practical Concerns and Controversies in the Management of Alcoholic Hepatitis.

Authors:  Gene Y Im; Michael R Lucey
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-08

Review 3.  Cell therapy in chronic liver disease.

Authors:  Clara T Nicolas; Yujia Wang; Scott L Nyberg
Journal:  Curr Opin Gastroenterol       Date:  2016-05       Impact factor: 3.287

Review 4.  Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; María Luisa Gutiérrez-García; Sonia Alonso-López; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

5.  Risks and predicting factors of bleeding complications in hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Hong-Ying Guo; Zheng-Guo Zhang; Yu-Yi Zhang; Xue Mei; Yu Liu; Jie-Fei Wang; Zhi-Ping Qian; Wei Yuan
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

Review 6.  Acute-on-chronic liver failure: terminology, mechanisms and management.

Authors:  Shiv K Sarin; Ashok Choudhury
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-03       Impact factor: 46.802

7.  Prevalence and risk factors of acute-on-chronic liver failure in a single center from Argentina.

Authors:  Cristian Dominguez; Eugenia Romero; Jorgelina Graciano; Jose Luis Fernandez; Luis Viola
Journal:  World J Hepatol       Date:  2016-12-08

8.  Circulating proteomic panels for diagnosis and risk stratification of acute-on-chronic liver failure in patients with viral hepatitis B.

Authors:  Zeyu Sun; Xiaoli Liu; Daxian Wu; Hainv Gao; Jing Jiang; Ying Yang; Jie Wu; Qikang Gao; Jie Wang; Zhengyi Jiang; Youping Xu; Xiao Xu; Lanjuan Li
Journal:  Theranostics       Date:  2019-01-30       Impact factor: 11.556

Review 9.  Emerging concepts in alcoholic hepatitis.

Authors:  Phoenix Fung; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2017-04-28

10.  Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders.

Authors:  Nuria García-Marchena; Daniel Silva-Peña; Ana Isabel Martín-Velasco; María Ángeles Villanúa; Pedro Araos; María Pedraz; Rosa Maza-Quiroga; Pablo Romero-Sanchiz; Gabriel Rubio; Estela Castilla-Ortega; Juan Suárez; Fernando Rodríguez de Fonseca; Antonia Serrano; Francisco Javier Pavón
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.